TEAD-YAP Interaction Inhibitors and MDM2 Binders from DNA-Encoded Indole-Focused Ugi Peptidomimetics.


Journal

Angewandte Chemie (International ed. in English)
ISSN: 1521-3773
Titre abrégé: Angew Chem Int Ed Engl
Pays: Germany
ID NLM: 0370543

Informations de publication

Date de publication:
09 11 2020
Historique:
received: 30 04 2020
revised: 20 05 2020
pubmed: 17 6 2020
medline: 30 3 2021
entrez: 16 6 2020
Statut: ppublish

Résumé

DNA-encoded combinatorial synthesis provides efficient and dense coverage of chemical space around privileged molecular structures. The indole side chain of tryptophan plays a prominent role in key, or "hot spot", regions of protein-protein interactions. A DNA-encoded combinatorial peptoid library was designed based on the Ugi four-component reaction by employing tryptophan-mimetic indole side chains to probe the surface of target proteins. Several peptoids were synthesized on a chemically stable hexathymidine adapter oligonucleotide "hexT", encoded by DNA sequences, and substituted by azide-alkyne cycloaddition to yield a library of 8112 molecules. Selection experiments for the tumor-relevant proteins MDM2 and TEAD4 yielded MDM2 binders and a novel class of TEAD-YAP interaction inhibitors that perturbed the expression of a gene under the control of these Hippo pathway effectors.

Identifiants

pubmed: 32537835
doi: 10.1002/anie.202006280
pmc: PMC7689693
doi:

Substances chimiques

Indoles 0
Peptidomimetics 0
Transcription Factors 0
DNA 9007-49-2
MDM2 protein, human EC 2.3.2.27
Proto-Oncogene Proteins c-mdm2 EC 2.3.2.27

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

20338-20342

Subventions

Organisme : NIGMS NIH HHS
ID : R01 GM097082
Pays : United States

Informations de copyright

© 2020 The Authors. Published by Wiley-VCH Verlag GmbH & Co. KGaA.

Références

Proc Natl Acad Sci U S A. 2004 Aug 3;101(31):11287-92
pubmed: 15269345
Nature. 2007 Dec 13;450(7172):1001-9
pubmed: 18075579
ChemMedChem. 2010 Apr 6;5(4):584-90
pubmed: 20229565
ACS Med Chem Lett. 2014 Jul 14;5(9):993-8
pubmed: 25221655
Chembiochem. 2013 Jul 8;14(10):1218-25
pubmed: 23780915
ACS Chem Biol. 2017 Nov 17;12(11):2730-2736
pubmed: 29043777
Nat Rev Cancer. 2014 Apr;14(4):248-62
pubmed: 24622521
Chem Biol. 2015 Jun 18;22(6):689-703
pubmed: 26091166
Angew Chem Int Ed Engl. 2020 Nov 9;59(46):20338-20342
pubmed: 32537835
Expert Opin Drug Discov. 2019 Aug;14(8):735-753
pubmed: 31111767
Structure. 2015 Nov 3;23(11):2076-86
pubmed: 26592798
Nat Cell Biol. 2015 Sep;17(9):1218-27
pubmed: 26258633
J Med Chem. 2018 Jun 28;61(12):5057-5072
pubmed: 29251924
PLoS One. 2012;7(3):e32839
pubmed: 22427896
ACS Chem Biol. 2019 Dec 20;14(12):2909-2921
pubmed: 31742995
Chemistry. 2012 Jun 18;18(25):7729-37
pubmed: 22588840
Cell Chem Biol. 2019 Mar 21;26(3):378-389.e13
pubmed: 30581134
Medchemcomm. 2017 May 1;8(5):1046-1052
pubmed: 29034069
Bioorg Med Chem Lett. 2019 Aug 15;29(16):2316-2319
pubmed: 31235263
Bioorg Med Chem. 2014 Apr 1;22(7):2353-65
pubmed: 24593905
Angew Chem Int Ed Engl. 2015 Nov 16;54(47):13933-6
pubmed: 26385475
Angew Chem Int Ed Engl. 2008;47(17):3196-201
pubmed: 18366035
Nucleic Acids Res. 2019 Jan 8;47(D1):D607-D613
pubmed: 30476243
J Med Chem. 2019 Feb 14;62(3):1291-1305
pubmed: 30640473
Angew Chem Int Ed Engl. 2011 Mar 14;50(12):2680-8
pubmed: 21341346
J Med Chem. 2015 Jun 25;58(12):4857-73
pubmed: 25719868
Trends Cancer. 2019 May;5(5):297-307
pubmed: 31174842
Chem Sci. 2017 May 1;8(5):3356-3361
pubmed: 28507705
J Mol Biol. 1998 Jul 3;280(1):1-9
pubmed: 9653027
Proc Natl Acad Sci U S A. 2019 May 14;116(20):9877-9882
pubmed: 31043565
J Med Chem. 2019 Nov 14;62(21):9732-9742
pubmed: 31603323
Nat Rev Cancer. 2013 Apr;13(4):246-57
pubmed: 23467301

Auteurs

Verena B K Kunig (VBK)

TU Dortmund University, Faculty of Chemistry and Chemical Biology, Otto-Hahn-Strasse 6, 44227, Dortmund, Germany.

Marco Potowski (M)

TU Dortmund University, Faculty of Chemistry and Chemical Biology, Otto-Hahn-Strasse 6, 44227, Dortmund, Germany.

Mohammad Akbarzadeh (M)

Max Planck Institute of Molecular Physiology, Department of Chemical Biology, Otto-Hahn-Strasse 11, 44227, Dortmund, Germany.

Mateja Klika Škopić (M)

TU Dortmund University, Faculty of Chemistry and Chemical Biology, Otto-Hahn-Strasse 6, 44227, Dortmund, Germany.

Denise Dos Santos Smith (D)

TU Dortmund University, Faculty of Chemistry and Chemical Biology, Otto-Hahn-Strasse 6, 44227, Dortmund, Germany.

Lukas Arendt (L)

TU Dortmund University, Faculty of Statistics, Vogelpothsweg 87, 44227, Dortmund, Germany.

Ina Dormuth (I)

TU Dortmund University, Faculty of Statistics, Vogelpothsweg 87, 44227, Dortmund, Germany.

Hélène Adihou (H)

Medicinal Chemistry, Research and Early Development, Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals R&D, AstraZeneca, 43150, Gothenburg, Sweden.
AstraZeneca-Max Planck Institute Satellite Unit, Max-Planck Institute of Molecular Physiology, Department of Chemical Biology, Otto-Hahn-Strasse 11, 44227, Dortmund, Germany.

Blaž Andlovic (B)

Lead Discovery Center GmbH (Germany), Otto-Hahn-Strasse 15, 44227, Dortmund, Germany.
Laboratory of Chemical Biology, Department of Biomedical Engineering and Institute for Complex Molecular Systems, Eindhoven University of Technology, Den Dolech 2, 5612, AZ, Eindhoven, The Netherlands.

Hacer Karatas (H)

Max Planck Institute of Molecular Physiology, Department of Chemical Biology, Otto-Hahn-Strasse 11, 44227, Dortmund, Germany.

Shabnam Shaabani (S)

University of Groningen, Drug Design, Deusinglaan 1, 7313, AV, Groningen, The Netherlands.

Tryfon Zarganes-Tzitzikas (T)

University of Groningen, Drug Design, Deusinglaan 1, 7313, AV, Groningen, The Netherlands.

Constantinos G Neochoritis (CG)

University of Groningen, Drug Design, Deusinglaan 1, 7313, AV, Groningen, The Netherlands.
University of Crete, Department of Chemistry, 70013, Heraklion, Greece.

Ran Zhang (R)

University of Groningen, Drug Design, Deusinglaan 1, 7313, AV, Groningen, The Netherlands.

Matthew Groves (M)

University of Groningen, Drug Design, Deusinglaan 1, 7313, AV, Groningen, The Netherlands.

Stéphanie M Guéret (SM)

Medicinal Chemistry, Research and Early Development, Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals R&D, AstraZeneca, 43150, Gothenburg, Sweden.
AstraZeneca-Max Planck Institute Satellite Unit, Max-Planck Institute of Molecular Physiology, Department of Chemical Biology, Otto-Hahn-Strasse 11, 44227, Dortmund, Germany.

Christian Ottmann (C)

Laboratory of Chemical Biology, Department of Biomedical Engineering and Institute for Complex Molecular Systems, Eindhoven University of Technology, Den Dolech 2, 5612, AZ, Eindhoven, The Netherlands.

Jörg Rahnenführer (J)

TU Dortmund University, Faculty of Statistics, Vogelpothsweg 87, 44227, Dortmund, Germany.

Roland Fried (R)

TU Dortmund University, Faculty of Statistics, Vogelpothsweg 87, 44227, Dortmund, Germany.

Alexander Dömling (A)

University of Groningen, Drug Design, Deusinglaan 1, 7313, AV, Groningen, The Netherlands.

Andreas Brunschweiger (A)

TU Dortmund University, Faculty of Chemistry and Chemical Biology, Otto-Hahn-Strasse 6, 44227, Dortmund, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH